Improving Care for People with Chronic Respiratory Diseases: Taking a Policy Lens

IF 3.4 3区医学 Q2 MEDICINE, RESEARCH & EXPERIMENTAL

Advances in Therapy Pub Date : 2025-04-19 DOI:10.1007/s12325-025-03191-x

Aislinn Santoni, Suzanne Wait, Job F. M. van Boven, Zachary Desson, Christine Jenkins, Ee Ming Khoo, Tonya Winders, Dawei Yang, Arzu Yorgancioglu

引用次数: 0

Abstract

Chronic respiratory diseases (CRDs) affect almost 470 million people worldwide, and this number is growing. CRDs take a significant toll on the capacity of health systems and economies, and their effect on people’s lives can be devastating. Despite high rates of prevalence and mortality, CRDs are underprioritised by policymakers and governments. Tackling these conditions will require a holistic, multisectoral approach, including government-led strategies for prevention, diagnosis, management and investment in research. In this article, we provide a clear rationale for prioritising CRDs to advance population health. Proactive steps in countries of all income levels must be taken promptly to limit the growing prevalence and impact of CRDs both now and in the future.

查看原文本刊更多论文

改善对慢性呼吸系统疾病患者的护理：从政策角度看问题。

慢性呼吸道疾病（CRDs）影响着全世界近4.7亿人，而且这一数字还在增长。慢性疾病对卫生系统和经济的能力造成重大损失，对人们生活的影响可能是毁灭性的。尽管流行率和死亡率很高，但政策制定者和政府对慢性疾病的重视程度不够。解决这些问题将需要一种全面的、多部门的方法，包括政府主导的预防、诊断、管理和研究投资战略。在本文中，我们提供了一个明确的理由，优先考虑crd，以促进人口健康。所有收入水平的国家都必须迅速采取积极措施，在现在和将来限制慢性疾病日益流行和影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Advances in Therapy 医学-药学

CiteScore

7.20

自引率

2.60%

发文量

353

审稿时长

6-12 weeks

期刊介绍： Advances in Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged. The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Advances in Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.